DF Dent & Co’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$283K Sell
4,910
-200
-4% -$11.5K 0.01% 246
2026
Q1
$310K Buy
+5,110
New +$298K 0.01% 241
2025
Q4
– Sell
-5,110
Closed -$230K – 267
2025
Q3
$230K Buy
+5,110
New +$239K ﹤0.01% 258
2024
Q2
– Sell
-4,456
Closed -$242K – 245
2024
Q1
$242K Sell
4,456
-577
-11% -$29.4K ﹤0.01% 245
2023
Q4
$258K Buy
+5,033
New +$264K ﹤0.01% 228
2023
Q3
– Sell
-4,567
Closed -$292K – 257
2023
Q2
$292K Sell
4,567
-8
-0.2% -$536 ﹤0.01% 226
2023
Q1
$317K Buy
4,575
+318
+7% +$22.4K ﹤0.01% 212
2022
Q4
$306K Buy
4,257
+484
+13% +$36.5K ﹤0.01% 210
2022
Q3
$268K Buy
3,773
+123
+3% +$8.92K ﹤0.01% 211
2022
Q2
$281K Sell
3,650
-430
-11% -$32.7K ﹤0.01% 204
2022
Q1
$298K Buy
4,080
+492
+14% +$33K ﹤0.01% 216
2021
Q4
$224K Buy
3,588
+105
+3% +$6.16K ﹤0.01% 240
2021
Q3
$206K Hold
3,483
– – ﹤0.01% 234
2021
Q2
$233K Hold
3,483
– – ﹤0.01% 222
2021
Q1
$220K Sell
3,483
-100
-3% -$6.22K ﹤0.01% 221
2020
Q4
$222K Sell
3,583
-268
-7% -$16.5K ﹤0.01% 214
2020
Q3
$232K Hold
3,851
– – ﹤0.01% 202
2020
Q2
$226K Buy
+3,851
New +$230K ﹤0.01% 186
2020
Q1
– Sell
-3,591
Closed -$231K – 197
2019
Q4
$231K Buy
+3,591
New +$206K ﹤0.01% 206

Other funds holding BMY

DF Dent & Co's BMY Position: Q2 2026 in Review

DF Dent & Co reduced its Bristol-Myers Squibb (BMY) stake by 3.9% in Q2 2026, selling an estimated $11.5K and leaving 4,910 shares worth $283K. The position accounts for 0.01% of the portfolio, ranked #246.

DF Dent & Co first reported a position in BMY in Q4 2019 and has held it in 19 quarters since. The position peaked at $317K in Q1 2023. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • DF Dent & Co held 4,910 shares of Bristol-Myers Squibb worth $283K as of Q2 2026.
  • DF Dent & Co sold 200 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5K.
  • Bristol-Myers Squibb made up 0.01% of DF Dent & Co's portfolio in Q2 2026, its #246 holding.
  • DF Dent & Co first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 19 quarters since.
  • DF Dent & Co's Bristol-Myers Squibb position peaked at $317K in Q1 2023.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on DF Dent & Co's 13F filing for Q2 2026, filed 14 Aug 2026.